11.3 Automated Dispensing & Telepharmacy
Key Takeaways
- NYSED's Office of the Professions has advised that Automated Dispensing Machines (ADMs) selling prescription drugs to customers outside a pharmacy's registered area violate Education Law §§6802(1) and 6808(1) and 8 NYCRR §63.6, with responsibility resting on pharmacy ownership and the Supervising Pharmacist.
- Automated Dispensing Devices (ADDs) at nursing homes/residential health care facilities are governed separately by DOH's Bureau of Narcotic Enforcement (BNE) guideline for registered community pharmacy operation of ADDs — not NYSED's retail rules.
- Every medication dispensed from an ADD, including controlled substances, requires a valid patient-specific order, and controlled-substance ADDs require a machine-specific DEA-ADD registration number in addition to NY pharmacy licensing.
- Access to an ADD is restricted to personnel jointly authorized by facility administration and the pharmacist-in-charge (PIC).
- New York has no enacted general telepharmacy statute as of 2026 — Assembly Bill A623 (2025-26 session) remains in committee; the confirmed remote-access mechanism is 8 NYCRR §63.6(a)'s shared database provisions, which allow remote order processing, not an unstaffed remote dispensing site.
Automated Dispensing in Retail Pharmacies
New York regulates automated dispensing two different ways depending on setting, and MPJE candidates need to keep the two tracks separate: retail/community pharmacy oversight runs through NYSED's Office of the Professions under Education Law and 8 NYCRR Part 63, while automated dispensing of controlled substances in institutional settings (nursing homes, residential health care facilities) runs through the DOH Bureau of Narcotic Enforcement (BNE).
The "Outside the Registered Area" Trap
NYSED's Office of the Professions issued an advisory notice addressing a specific, real compliance problem: pharmacies installing Automated Dispensing Machines (ADMs) that store and sell prescription drugs to customers outside the pharmacy's registered area — for example, a kiosk elsewhere in a retail store, physically separated from the licensed pharmacy department. NYSED considers this a violation, citing:
| Citation | What it establishes |
|---|---|
| Education Law §6802(1) | Defines a "pharmacy" as any location where drugs are compounded, dispensed, or retailed |
| Education Law §6808(1) | Requires Department registration before any retail sale of prescription drugs |
| 8 NYCRR §63.6 | Sets pharmacy operation requirements tied to the registered location |
The advisory places responsibility squarely on "the ownership of the pharmacy and the Supervising Pharmacist" for compliance with all applicable laws and regulations. The exam-relevant rule of thumb: an ADM is fine inside the registered pharmacy's four walls under pharmacist oversight; an ADM dispensing prescription drugs from a location outside that registered footprint is functionally an unregistered second pharmacy.
Automated Dispensing in Long-Term Care (DOH/BNE Track)
A separate framework governs Automated Dispensing Devices (ADDs) used at nursing homes and residential health care facilities (RHCFs). DOH's Bureau of Narcotic Enforcement has issued a specific guideline covering registered community (retail) pharmacy operation of ADDs in RHCFs. Under this framework:
- All medications dispensed from an ADD — including controlled substances — must be pursuant to a valid, patient-specific order.
- Access to the ADD is restricted to personnel jointly authorized by the facility administration and the pharmacist-in-charge (PIC): pharmacy and facility nursing staff, registered pharmacy technicians, and pharmacy aides.
- A pharmacy dispensing controlled substances through an ADD must obtain a machine-specific DEA-ADD registration number in addition to its New York State pharmacy licensing.
- Consultant pharmacist oversight in the nursing-home setting continues independently (e.g., monthly chart reviews); the ADD does not replace that oversight.
Two Different Regulators, One Concept
| Setting | Regulator | Core rule |
|---|---|---|
| Retail pharmacy, ADM inside registered area | NYSED / Board of Pharmacy | Permitted under pharmacist supervision |
| Retail pharmacy, ADM outside registered area | NYSED / Board of Pharmacy | Advisory-flagged violation (§6802(1), §6808(1), §63.6) |
| ADD for controlled substances at RHCF | DOH Bureau of Narcotic Enforcement | Patient-specific order, joint access authorization, machine-specific DEA-ADD number |
Telepharmacy: Proposed, Not Yet Law
Unlike a growing number of states, New York does not currently have an enacted general telepharmacy statute authorizing an unstaffed or technician-only remote dispensing site supervised only by video/audio link. A bill to establish telepharmacy (Assembly Bill A623, 2025-26 session) was introduced January 8, 2025 and, as of this writing, remains in the Assembly Higher Education Committee — it has not passed either chamber or been delivered to the Governor. MPJE candidates should not assume NY has adopted the "remote site," "satellite consultation site," or "remote supervision" telepharmacy model used in other states unless and until such a bill is enacted.
Remote Order Processing vs Remote Dispensing
What NY does have, and what candidates should not confuse with telepharmacy, is 8 NYCRR §63.6(a)'s provision for common/shared electronic database access — reinforced by the 2026 shared pharmacy services law — which lets a registered pharmacist access a pharmacy's database from inside or outside the physical pharmacy to perform order-processing functions such as verification. This is remote order processing by a licensed pharmacist connected to a database, not an unstaffed remote dispensing site staffed only by a technician. The distinction matters: NY permits the former today; the latter remains a legislative proposal.
Where the Consultant Pharmacist Fits
An ADD does not substitute for the ongoing clinical oversight a nursing home already owes its residents. New York nursing homes are required to retain a consultant pharmacist, who reviews each resident's medication chart on a monthly basis, with additional review triggered by a new admission or transfer and by any new prescription for an antipsychotic drug. Installing an ADD changes how a dose physically reaches the resident; it does not change who is accountable for catching a duplicate therapy, an unnecessary drug, or a dosing error — that responsibility still runs through the pharmacist-in-charge and the facility's consultant pharmacist, not the machine.
Traps
- An ADM outside a pharmacy's registered footprint is an NYSED-flagged violation, even if it sits in the same building.
- Controlled-substance ADDs in nursing homes need a machine-specific DEA-ADD number — a general pharmacy DEA registration is not enough.
- NY has no enacted telepharmacy statute as of 2026 — do not select a "remote dispensing site" answer as current NY law.
- Remote order processing (verification via shared database) is authorized; an unstaffed remote dispensing site is not.
An ADM installed by a NY pharmacy dispenses prescription drugs to customers from a kiosk in the front of the store, outside the pharmacy's registered area. Under NYSED's advisory position, who bears responsibility for this violation?
A nursing home's automated dispensing device dispenses a controlled substance to a resident. What must be true for this to be compliant with New York's DOH/BNE framework?
As of 2026, what is the status of general telepharmacy (unstaffed remote dispensing sites) in New York?
A NY pharmacist logs into her pharmacy's database from home to verify a prescription's dosage and check for drug interactions before it is filled. This is best characterized as which of the following under NY law?